193 related articles for article (PubMed ID: 19483657)
1. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia.
Funk AJ; Rumbaugh G; Harotunian V; McCullumsmith RE; Meador-Woodruff JH
Neuroreport; 2009 Jul; 20(11):1019-22. PubMed ID: 19483657
[TBL] [Abstract][Full Text] [Related]
2. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia.
Kristiansen LV; Patel SA; Haroutunian V; Meador-Woodruff JH
Synapse; 2010 Jul; 64(7):495-502. PubMed ID: 20175224
[TBL] [Abstract][Full Text] [Related]
3. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.
Kristiansen LV; Beneyto M; Haroutunian V; Meador-Woodruff JH
Mol Psychiatry; 2006 Aug; 11(8):737-47, 705. PubMed ID: 16702973
[TBL] [Abstract][Full Text] [Related]
4. Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.
Dean B; Gibbons AS; Boer S; Uezato A; Meador-Woodruff J; Scarr E; McCullumsmith RE
Aust N Z J Psychiatry; 2016 Mar; 50(3):275-83. PubMed ID: 26013316
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia.
Ohnuma T; Kato H; Arai H; Faull RL; McKenna PJ; Emson PC
Neuroreport; 2000 Sep; 11(14):3133-7. PubMed ID: 11043537
[TBL] [Abstract][Full Text] [Related]
6. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
Beneyto M; Meador-Woodruff JH
Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.
Dracheva S; Marras SA; Elhakem SL; Kramer FR; Davis KL; Haroutunian V
Am J Psychiatry; 2001 Sep; 158(9):1400-10. PubMed ID: 11532724
[TBL] [Abstract][Full Text] [Related]
8. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor.
Komiyama NH; Watabe AM; Carlisle HJ; Porter K; Charlesworth P; Monti J; Strathdee DJ; O'Carroll CM; Martin SJ; Morris RG; O'Dell TJ; Grant SG
J Neurosci; 2002 Nov; 22(22):9721-32. PubMed ID: 12427827
[TBL] [Abstract][Full Text] [Related]
9. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications.
Carty NC; Xu J; Kurup P; Brouillette J; Goebel-Goody SM; Austin DR; Yuan P; Chen G; Correa PR; Haroutunian V; Pittenger C; Lombroso PJ
Transl Psychiatry; 2012 Jul; 2(7):e137. PubMed ID: 22781170
[TBL] [Abstract][Full Text] [Related]
11. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family.
Kim JH; Liao D; Lau LF; Huganir RL
Neuron; 1998 Apr; 20(4):683-91. PubMed ID: 9581761
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia.
Pinner AL; Haroutunian V; Meador-Woodruff JH
Schizophr Res; 2014 Apr; 154(1-3):36-41. PubMed ID: 24568864
[TBL] [Abstract][Full Text] [Related]
13. Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia.
Moody CL; Funk AJ; Devine E; Devore Homan RC; Boison D; McCullumsmith RE; O'Donovan SM
Schizophr Bull; 2020 Apr; 46(3):690-698. PubMed ID: 32275755
[TBL] [Abstract][Full Text] [Related]
14. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia.
Toyooka K; Iritani S; Makifuchi T; Shirakawa O; Kitamura N; Maeda K; Nakamura R; Niizato K; Watanabe M; Kakita A; Takahashi H; Someya T; Nawa H
J Neurochem; 2002 Nov; 83(4):797-806. PubMed ID: 12421351
[TBL] [Abstract][Full Text] [Related]
15. Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation.
Matosin N; Fernandez-Enright F; Fung SJ; Lum JS; Engel M; Andrews JL; Huang XF; Weickert CS; Newell KA
Acta Neuropathol; 2015 Jul; 130(1):119-29. PubMed ID: 25778620
[TBL] [Abstract][Full Text] [Related]
16. Postsynaptic Density-95 Isoform Abnormalities in Schizophrenia.
Funk AJ; Mielnik CA; Koene R; Newburn E; Ramsey AJ; Lipska BK; McCullumsmith RE
Schizophr Bull; 2017 Jul; 43(4):891-899. PubMed ID: 28126896
[TBL] [Abstract][Full Text] [Related]
17. Synaptic Ras GTPase activating protein regulates pattern formation in the trigeminal system of mice.
Barnett MW; Watson RF; Vitalis T; Porter K; Komiyama NH; Stoney PN; Gillingwater TH; Grant SG; Kind PC
J Neurosci; 2006 Feb; 26(5):1355-65. PubMed ID: 16452659
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.
Toro C; Deakin JF
Schizophr Res; 2005 Dec; 80(2-3):323-30. PubMed ID: 16140506
[TBL] [Abstract][Full Text] [Related]
19. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia.
Beneyto M; Meador-Woodruff JH
Synapse; 2006 Dec; 60(8):585-98. PubMed ID: 16983646
[TBL] [Abstract][Full Text] [Related]
20. Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.
Funk AJ; McCullumsmith RE; Haroutunian V; Meador-Woodruff JH
Neuropsychopharmacology; 2012 Mar; 37(4):896-905. PubMed ID: 22048463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
